A detailed history of Stansberry Asset Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Stansberry Asset Management, LLC holds 59,281 shares of NVO stock, worth $6.64 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares
59,281
Previous 52,062 13.87%
Holding current value
$6.64 Million
Previous $6.68 Million 26.59%
% of portfolio
1.22%
Previous 0.99%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $885,843 - $1.06 Million
7,219 Added 13.87%
59,281 $8.46 Million
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $527,091 - $701,619
5,162 Added 11.01%
52,062 $6.68 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $2.16 Million - $4.73 Million
23,701 Added 102.16%
46,900 $4.27 Million
Q2 2023

Aug 11, 2023

BUY
$155.98 - $172.65 $196,378 - $217,366
1,259 Added 5.74%
23,199 $3.75 Million
Q1 2023

May 12, 2023

BUY
$132.34 - $159.14 $1.29 Million - $1.56 Million
9,779 Added 80.41%
21,940 $3.49 Million
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $224,687 - $296,508
2,191 Added 21.98%
12,161 $1.65 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $78,320 - $96,116
822 Added 8.99%
9,970 $994,000
Q2 2022

Aug 15, 2022

SELL
$103.24 - $121.81 $28,803 - $33,984
-279 Reduced 2.96%
9,148 $1.02 Million
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $347,263 - $419,774
3,730 Added 65.47%
9,427 $1.05 Million
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $148,326 - $181,122
1,547 Added 37.28%
5,697 $638,000
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $48,625 - $61,413
576 Added 16.12%
4,150 $398,000
Q2 2021

Aug 16, 2021

BUY
$67.66 - $84.76 $241,816 - $302,932
3,574 New
3,574 $299,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Stansberry Asset Management, LLC Portfolio

Follow Stansberry Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stansberry Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stansberry Asset Management, LLC with notifications on news.